Beta Bionics is evolving into a multi-product diabetes company with the upcoming launch of its FDA-cleared Mint patch pump in the first quarter of 2027. This new product will broaden the company's market reach and accelerate growth through pharmacy channels, complementing its existing 3D Intelligence system to enhance patient retention and differentiation. Although 2026 revenue guidance was lowered due to delayed demand, this positions Beta Bionics for stronger growth in 2027 as patients await the Mint launch. A $150 million equity raise will support the rollout and expansion of Mint, balancing short-term dilution against long-term growth potential.
Beta Bionics' shift toward a multi-engine growth story is timely context for health sector investors. For readers following the health sector, here is Pluang's market snapshot as of Sep 17, 2026 18:11 WIB: Of 91 priced US health stocks, 63 rose and 25 fell. Notable movers include Agilent Technologies Inc at USD 151.19 with a 1-day change of -1.63% and a typical hold time of 37 days, Novavax Inc at USD 9.50 with a 1-day change of +1.60% and Pluang order activity showing 0% Sell / 100% Buy with a typical hold time of 59 days, and DENTSPLY SIRONA Inc at USD 9.98 with a 1-day change of -1.58% and a typical hold time of 71 days.
Disc Medicine announced a webcast on October 19, 2026, to discuss topline results from its APOLLO Phase 3 trial of bitopertin, an investigational oral drug for erythropoietic protoporphyria (EPP). Bitopertin targets glycine transporter 1 to modulate ...
Tech analyst James Altucher draws a parallel between the 1865 coal consumption surge and AI's increasing power needs, despite efficiency gains. He highlights Elon Musk's unique strategy of vertical integration, including plans to build AI data center...
BitTorrent has completed its inaugural burn of BTT tokens, using 100% of decentralized service revenue to repurchase and permanently remove over 21.6 trillion tokens from circulation. This marks a key step in BitTorrent's long-term strategy to create...
NEAR token fell about 17% over the week, trading near $4.895 with a low of $4.527, staying above the critical $4.30 support level. Analyst Giannis Andreou highlights $4.30 as a key pivot point in 2024, with potential for NEAR to rebound toward $6 and...
Crude oil prices remained near recent highs as Ukraine launched drone strikes on an oil terminal in St. Petersburg, Russia, causing fires and uncertainty about damage. The terminal exports about 120,000 barrels per day of refined products. Meanwhile,...
